<DOC>
	<DOCNO>NCT00537615</DOCNO>
	<brief_summary>The purpose study investigate absorption , metabolism excretion [ 14C ] PD 0332334 characterize plasma , fecal urinary radioactivity identify metabolite [ 14C ] PD 0332334 .</brief_summary>
	<brief_title>An Open-label Study Investigate Absorption , Metabolism Excretion Radiolabeled PD 0332334 Six Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion eligible enrollment trial : 1 . Healthy male subject age 18 55 year , inclusive . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . 2 . Body Mass Index ( BMI ) approximately 18 30 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . 3 . Evidence personally sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect trial . 4 . Subjects willing able comply schedule confinement period , treatment plan , laboratory test , trial procedure . Subjects present follow included trial : 1 . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , orallergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . 2 . Subjects enrol previous radionucleotide study receive radiotherapy within 12 month prior screen total radioactivity would exceed acceptable dosimetry . 3 . Subjects whose occupation require exposure radiation monitoring radiation exposure .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>